Base de dados : MEDLINE
Pesquisa : B03.440.860.580.553.553.355 [Categoria DeCS]
Referências encontradas : 538 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 54 ir para página                         

  1 / 538 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28893363
[Au] Autor:Trembizki E; Buckley C; Bletchly C; Nimmo GR; Whiley DM
[Ad] Endereço:1​UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland 4029, Australia.
[Ti] Título:High levels of macrolide-resistant Mycoplasma genitalium in Queensland, Australia.
[So] Source:J Med Microbiol;66(10):1451-1453, 2017 Oct.
[Is] ISSN:1473-5644
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:The macrolide azithromycin is recommended for treatment of Mycoplasma genitalium infection; however, M. genitalium strains possessing macrolide resistance-mediating mutations (MRMMs) are increasingly being reported. Here, we used the SpeeDx ResistancePlus MG kit, which provides simultaneous detection of M. genitalium and MRMMs, to assess MRMM carriage among M. genitalium infections in Queensland, Australia. Performance characteristics of the ResistancePlus MG kit for M. genitalium detection were compared to in-house PCR. Available M. genitalium PCR-positive (n=67) and negative (n=281) samples from the years 2011 to 2017 were tested using the SpeeDx ResistancePlus MG kit. In total, 63.6 % M. genitalium-positive samples were indicated to harbour MRMMs. The ResistancePlus MG method provided sensitivity and specificity of 97 and 99.6 % respectively compared to in-house PCR for M. genitalium detection. Such high levels of macrolide-resistant M. genitalium raise further concerns over future use of azithromycin for treatment of M. genitalium infection.
[Mh] Termos MeSH primário: Antibacterianos/farmacologia
Azitromicina/farmacologia
Macrolídeos/farmacologia
Infecções por Mycoplasma/epidemiologia
Infecções por Mycoplasma/microbiologia
Mycoplasma genitalium/efeitos dos fármacos
[Mh] Termos MeSH secundário: Feminino
Seres Humanos
Masculino
Queensland/epidemiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Anti-Bacterial Agents); 0 (Macrolides); 83905-01-5 (Azithromycin)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171018
[Lr] Data última revisão:
171018
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170913
[St] Status:MEDLINE
[do] DOI:10.1099/jmm.0.000584


  2 / 538 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28838079
[Au] Autor:Golden MR; Workowski KA; Bolan G
[Ad] Endereço:Center for AIDS and STD, University of Washington, Seattle.
[Ti] Título:Developing a Public Health Response to Mycoplasma genitalium.
[So] Source:J Infect Dis;216(suppl_2):S420-S426, 2017 Jul 15.
[Is] ISSN:1537-6613
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Although Mycoplasma genitalium is increasingly recognized as a sexually transmitted pathogen, at present there is no defined public health response to this relatively newly identified sexually transmitted infection. Currently available data are insufficient to justify routinely screening any defined population for M. genitalium infection. More effective therapies, data on acceptability of screening and its impact on clinical outcomes, and better information on the natural history of infection will likely be required before the value of potential screening programs can be adequately assessed. Insofar as diagnostic tests are available or become available in the near future, clinicians and public health agencies should consider integrating M. genitalium testing into the management of persons with sexually transmitted infection (STI) syndromes associated with the infection (ie urethritis, cervicitis, and pelvic inflammatory disease) and their sex partners. Antimicrobial-resistant M. genitalium is a significant problem and may require clinicians and public health authorities to reconsider the management of STI syndromes in an effort to prevent the emergence of ever more resistant M. genitalium infections.
[Mh] Termos MeSH primário: Infecções por Mycoplasma/epidemiologia
Mycoplasma genitalium/isolamento & purificação
Saúde Pública
Doenças Bacterianas Sexualmente Transmissíveis/epidemiologia
[Mh] Termos MeSH secundário: Antibacterianos/uso terapêutico
Farmacorresistência Bacteriana
Feminino
Seres Humanos
Masculino
Infecções por Mycoplasma/complicações
Infecções por Mycoplasma/tratamento farmacológico
Parceiros Sexuais
Doenças Bacterianas Sexualmente Transmissíveis/complicações
Doenças Bacterianas Sexualmente Transmissíveis/microbiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Anti-Bacterial Agents)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170906
[Lr] Data última revisão:
170906
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170826
[St] Status:MEDLINE
[do] DOI:10.1093/infdis/jix200


  3 / 538 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28838078
[Au] Autor:Wiesenfeld HC; Manhart LE
[Ad] Endereço:Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, and Magee-Womens Research Institute, Pittsburgh, Pennsylvania.
[Ti] Título:Mycoplasma genitalium in Women: Current Knowledge and Research Priorities for This Recently Emerged Pathogen.
[So] Source:J Infect Dis;216(suppl_2):S389-S395, 2017 Jul 15.
[Is] ISSN:1537-6613
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Health consequences of sexually transmitted diseases disproportionately affect women, making it important to determine whether newly emerged pathogens cause sequelae. Although the pathogenic role of Mycoplasma genitalium in male urethritis is clear, fewer studies have been conducted among women to determine its pathogenic role in the female reproductive tract. Pelvic inflammatory disease (PID) is an important cause of infertility and ectopic pregnancy, and Chlamydia trachomatis and Neisseria gonorrhoeae are recognized microbial causes. Emerging data demonstrate an association between M. genitalium and PID, and limited data suggest associations with infertility and preterm birth, yet the attributable risk for female genital tract infections remains to be defined. Further investigations are needed to better define the impact of M. genitalium on women's reproductive health. Importantly, prospective studies evaluating whether screening programs and targeted treatment of M. genitalium improve reproductive outcomes in women are necessary to guide public health policy for this emerging pathogen.
[Mh] Termos MeSH primário: Infecções por Mycoplasma/complicações
Infecções por Mycoplasma/diagnóstico
Mycoplasma genitalium/isolamento & purificação
Doença Inflamatória Pélvica/microbiologia
Cervicite Uterina/microbiologia
[Mh] Termos MeSH secundário: Feminino
Seres Humanos
Infertilidade Feminina/etiologia
Masculino
Doença Inflamatória Pélvica/complicações
Gravidez
Gravidez Ectópica/etiologia
Nascimento Prematuro/etiologia
Fatores de Risco
Cervicite Uterina/complicações
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170906
[Lr] Data última revisão:
170906
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170826
[St] Status:MEDLINE
[do] DOI:10.1093/infdis/jix198


  4 / 538 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28838077
[Au] Autor:McGowin CL; Totten PA
[Ad] Endereço:Departments of 1 Microbiology, Immunology, and Parasitology.
[Ti] Título:The Unique Microbiology and Molecular Pathogenesis of Mycoplasma genitalium.
[So] Source:J Infect Dis;216(suppl_2):S382-S388, 2017 Jul 15.
[Is] ISSN:1537-6613
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Mycoplasma genitalium is increasingly appreciated as a common cause of sexually transmitted disease syndromes, including urethritis in men and cervicitis, endometritis, pelvic inflammatory disease, and possibly preterm birth, tubal factor infertility, and ectopic pregnancy in women. Despite these disease associations, which parallel those of Chlamydia trachomatis and Neisseria gonorrhoeae, the mechanisms by which this pathogen elicits inflammation, causes cellular damage, and persists in its only natural host (humans) are unique and are not fully understood. The purpose of this review is to briefly provide a historical background on the discovery, microbiology, and recognition of M. genitalium as a pathogen, and then summarize the recent advances in our understanding of the molecular biology and pathogenesis of this unique urogenital organism. Collectively, the basic scientific discussions herein should provide a framework for understanding the clinical and epidemiological outcomes described in the accompanying articles in this supplemental issue.
[Mh] Termos MeSH primário: Evasão da Resposta Imune
Infecções por Mycoplasma/imunologia
Mycoplasma genitalium/genética
Mycoplasma genitalium/patogenicidade
Doenças Bacterianas Sexualmente Transmissíveis/imunologia
[Mh] Termos MeSH secundário: Feminino
Genoma Bacteriano
Seres Humanos
Imunidade
Masculino
Mycoplasma genitalium/imunologia
Fatores de Risco
Doenças Bacterianas Sexualmente Transmissíveis/complicações
Uretrite/complicações
Uretrite/microbiologia
Cervicite Uterina/complicações
Cervicite Uterina/microbiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170906
[Lr] Data última revisão:
170906
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170826
[St] Status:MEDLINE
[do] DOI:10.1093/infdis/jix172


  5 / 538 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28838075
[Au] Autor:Martin DH; Manhart LE; Workowski KA
[Ad] Endereço:Department of Epidemiology, Tulane University School of Public Health.
[Ti] Título:Mycoplasma genitalium From Basic Science to Public Health: Summary of the Results From a National Institute of Allergy and Infectious Disesases Technical Consultation and Consensus Recommendations for Future Research Priorities.
[So] Source:J Infect Dis;216(suppl_2):S427-S430, 2017 Jul 15.
[Is] ISSN:1537-6613
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:This article lays out the research priorities for Mycoplasma genitalium research agreed upon by the participants in a 2016 National Institutes of Allergy and Infectious Diseases-funded Technical Consultation focused on this organism. The state of current knowledge concerning the microbiology, epidemiology, clinical manifestations of infection, treatment, and public health significance of M. genitalium reviewed at the meeting is described in detail in the individual articles included in this supplemental edition of the Journal of Infectious Diseases. Here we summarize the points made in these articles most relevant to the formulation of the research priorities listed in this article. The most important recommendation resulting from this Technical Consultation is the initiation of clinical trials designed to determine definitively whether screening for and treatment of M. genitalium infections in women and their sexual partners improve reproductive health in women and/or prevent human immunodeficiency virus transmission.
[Mh] Termos MeSH primário: Infecções por Mycoplasma/diagnóstico
Infecções por Mycoplasma/epidemiologia
Mycoplasma genitalium
Saúde Pública/tendências
Pesquisa/tendências
[Mh] Termos MeSH secundário: Adulto
Antibacterianos/uso terapêutico
Ensaios Clínicos como Assunto
Consenso
Resistência Microbiana a Medicamentos
Feminino
Infecções por HIV/prevenção & controle
Infecções por HIV/transmissão
Seres Humanos
Infecções por Mycoplasma/tratamento farmacológico
National Institutes of Health (U.S.)
Guias de Prática Clínica como Assunto
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Anti-Bacterial Agents)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170906
[Lr] Data última revisão:
170906
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170826
[St] Status:MEDLINE
[do] DOI:10.1093/infdis/jix147


  6 / 538 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28838074
[Au] Autor:Horner PJ; Martin DH
[Ad] Endereço:School of Social and Community Medicine, University of Bristol.
[Ti] Título:Mycoplasma genitalium Infection in Men.
[So] Source:J Infect Dis;216(suppl_2):S396-S405, 2017 Jul 15.
[Is] ISSN:1537-6613
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Mycoplasmagenitalium is one of the major causes of nongonococcal urethritis (NGU) worldwide but an uncommon sexually transmitted infection (STI) in the general population. The risk of sexual transmission is probably lower than for Chlamydia trachomatis. Infection in men is usually asymptomatic and it is likely that most men resolve infection without developing disease. The incubation period for NGU caused by Mycoplasma genitalium is probably longer than for NGU caused by C. trachomatis. The clinical characteristics of symptomatic NGU have not been shown to identify the pathogen specific etiology. Effective treatment of men and their sexual partner(s) is complicated as macrolide antimicrobial resistance is now common in many countries, conceivably due to the widespread use of azithromycin 1 g to treat STIs and the limited availability of diagnostic tests for M. genitalium. Improved outcomes in men with NGU and better antimicrobial stewardship are likely to arise from the introduction of diagnostic M. genitalium nucleic acid amplification testing including antimicrobial resistance testing in men with symptoms of NGU as well as in their current sexual partner(s). The cost effectiveness of these approaches needs further evaluation. The evidence that M. genitalium causes epididymo-orchitis, proctitis, and reactive arthritis and facilitates human immunodeficiency virus transmission in men is weak, although biologically plausible. In the absence of randomized controlled trials demonstrating cost effectiveness, screening of asymptomatic men cannot be recommended.
[Mh] Termos MeSH primário: Doenças Urogenitais Masculinas/microbiologia
Infecções por Mycoplasma/tratamento farmacológico
Mycoplasma genitalium/isolamento & purificação
Uretrite/microbiologia
[Mh] Termos MeSH secundário: Antibacterianos/uso terapêutico
Azitromicina/uso terapêutico
Farmacorresistência Bacteriana
Feminino
Seres Humanos
Macrolídeos/uso terapêutico
Masculino
Doenças Urogenitais Masculinas/tratamento farmacológico
Técnicas de Amplificação de Ácido Nucleico
Parceiros Sexuais
Uretrite/tratamento farmacológico
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Anti-Bacterial Agents); 0 (Macrolides); 83905-01-5 (Azithromycin)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170906
[Lr] Data última revisão:
170906
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170826
[St] Status:MEDLINE
[do] DOI:10.1093/infdis/jix145


  7 / 538 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28838073
[Au] Autor:Bradshaw CS; Jensen JS; Waites KB
[Ad] Endereço:Central Clinical School, Monash University.
[Ti] Título:New Horizons in Mycoplasma genitalium Treatment.
[So] Source:J Infect Dis;216(suppl_2):S412-S419, 2017 Jul 15.
[Is] ISSN:1537-6613
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Mycoplasmagenitalium is an important sexually transmitted pathogen responsible for both male and female genital tract disease. Appreciation of its significance in human disease has been hampered by its slow growth in culture, difficulty in isolating it, and lack of commercial molecular-based tests for rapid detection. Comparatively few in vitro data on antimicrobial susceptibility are available due to the scarcity of clinical isolates and difficulty in performing susceptibility tests to determine minimum inhibitory concentrations for M. genitalium. Antimicrobial agents that inhibit protein synthesis such as macrolides, along with fluoroquinolones that inhibit DNA replication, have been the treatments of choice for M. genitalium infections. Even though international guidelines recommend azithromycin as first-line treatment, rapid spread of macrolide resistance as well as emergence of quinolone resistance has occurred. Increasing rates of treatment failure have resulted in an urgent need for new therapies and renewed interest in other classes such as aminocyclitols, phenicols, and streptogramins as treatment alternatives. Limited data for new investigational antimicrobials such as the ketolide solithromycin suggest that this drug may eventually prove useful in management of some resistant M. genitalium infections, although it is not likely to achieve cure rates >80% in macrolide-resistant strains, in a similar range as recently reported for pristinamycin. However, agents with completely new targets and/or mechanisms that would be less likely to show cross-resistance with currently available drugs may hold the greatest promise. Lefamulin, a pleuromutilin, and new nonquinolone topoisomerase inhibitors are attractive possibilities that require further investigation.
[Mh] Termos MeSH primário: Antibacterianos/uso terapêutico
Descoberta de Drogas/classificação
Infecções por Mycoplasma/diagnóstico
Infecções por Mycoplasma/tratamento farmacológico
[Mh] Termos MeSH secundário: Azitromicina/uso terapêutico
Farmacorresistência Bacteriana
Feminino
Fluoroquinolonas/uso terapêutico
Seres Humanos
Masculino
Testes de Sensibilidade Microbiana
Mycoplasma genitalium
Quinolinas/uso terapêutico
Espectinomicina/uso terapêutico
Estreptograminas/uso terapêutico
Tetraciclinas/uso terapêutico
Tianfenicol/uso terapêutico
Falha de Tratamento
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Anti-Bacterial Agents); 0 (Fluoroquinolones); 0 (Quinolines); 0 (Streptogramins); 0 (Tetracyclines); 83905-01-5 (Azithromycin); 93AKI1U6QF (Spectinomycin); E66400VT9R (quinoline); FLQ7571NPM (Thiamphenicol)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170906
[Lr] Data última revisão:
170906
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170826
[St] Status:MEDLINE
[do] DOI:10.1093/infdis/jix132


  8 / 538 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28838072
[Au] Autor:Gaydos CA
[Ad] Endereço:Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland.
[Ti] Título:Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment.
[So] Source:J Infect Dis;216(suppl_2):S406-S411, 2017 Jul 15.
[Is] ISSN:1537-6613
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Background: Mycoplasma genitalium is very difficult to grow in culture but has been more able to be studied for disease associations since the advent of research molecular amplification assays. Polymerase chain reaction (PCR) and other molecular assays have demonstrated an association with adverse disease outcomes, such as urethritis or nongonococcal urethritis in men and adverse reproductive sequelae in women-for example, cervicitis, endometritis, and pelvic inflammatory disease (PID), including an association with risk for human immunodeficiency virus. The lack of commercially available diagnostic assays has limited widespread routine testing. Increasing reports of high rates of resistance to azithromycin detected in research studies have heightened the need available commercial diagnostic assays as well as standardized methods for detecting resistance markers. This review covers available molecular methods for the diagnosis of M. genitalium and assays to predict the antibiotic susceptibility to azithromycin. Methods: A PubMed (US National Library of Medicine and National Institutes of Health) search was conducted for literature published between 2000 and 2016, using the search terms Mycoplasma genitalium, M. genitalium, diagnosis, and detection. Results: Early PCR diagnostic tests focused on the MPa adhesion gene and the 16S ribosomal RNA gene. Subsequently, a transcription-mediated amplification assay targeting ribosomes was developed and widely used to study the epidemiology of M. genitalium. Newer methods have proliferated and include quantitative PCR for organism load, AmpliSens PCR, PCR for the pdhD gene, a PCR-based microarray for multiple sexually transmitted infections, and multiplex PCRs. None yet are cleared by the Food and Drug Administration in the United States, although several assays are CE marked in Europe. As well, many research assays, including PCR, gene sequencing, and melt curve analysis, have been developed to detect the 23S ribosomal RNA gene mutations that confer resistance to azithromycin. One recently developed assay can test for both M. genitalium and azithromycin resistance mutations at the same time. Conclusions: It is recommended that more commercial assays to both diagnose this organism and guide treatment choices should be developed and made available through regulatory approval. Research is needed to establish the cost-effectiveness of routine M. genitalium testing in symptomatic patients and screening in all individuals at high risk of acquiring and transmitting sexually transmitted infections.
[Mh] Termos MeSH primário: Infecções por Mycoplasma/diagnóstico
Mycoplasma genitalium/isolamento & purificação
[Mh] Termos MeSH secundário: Antibacterianos/uso terapêutico
Azitromicina/uso terapêutico
Farmacorresistência Bacteriana
Feminino
Seres Humanos
Macrolídeos/uso terapêutico
Masculino
Reação em Cadeia da Polimerase Multiplex
Mutação
Doença Inflamatória Pélvica/complicações
Doença Inflamatória Pélvica/microbiologia
RNA Ribossômico 16S/genética
Uretrite/complicações
Uretrite/microbiologia
Cervicite Uterina/complicações
Cervicite Uterina/microbiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Anti-Bacterial Agents); 0 (Macrolides); 0 (RNA, Ribosomal, 16S); 83905-01-5 (Azithromycin)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170906
[Lr] Data última revisão:
170906
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170826
[St] Status:MEDLINE
[do] DOI:10.1093/infdis/jix104


  9 / 538 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28762558
[Au] Autor:Edouard S; Tissot-Dupont H; Dubourg G; Bernard A; Fournier PE; Ravaux I; Stein A; Raoult D
[Ad] Endereço:Aix Marseille Univ, CNRS, IRD, INSERM, AP-HM, URMITE, IHU Méditerranée-Infection, Marseille, France.
[Ti] Título:Mycoplasma genitalium, an agent of reemerging sexually transmitted infections.
[So] Source:APMIS;125(10):916-920, 2017 Oct.
[Is] ISSN:1600-0463
[Cp] País de publicação:Denmark
[La] Idioma:eng
[Ab] Resumo:M. genitalium is a reemerging microorganism, responsible for sexually transmissible infections (STIs), with prevalence which varies depending on the country and population group studied. We report here M. genitalium prevalence among the specimens received for STI diagnosis in our routine microbiological laboratory in the university hospital in Marseille, France. We tested 4 624 samples from 3 793 patients using qPCR for M. genitalium, C. trachomatis, N. gonorrheae, T. pallidum. Of these samples, 528 (13.6%) patients were tested positive for at least one pathogen and 126 (3.3%) were positive for M. genitalium. M. genitalium is the second most prevalent micro-organism detected in women after C. trachomatis (10.4%) and the third most prevalent in men after C. trachomatis (5.1%) and N. gonorrhoeae (4.4%). We observed no significant differences between the prevalence of M. genitalium in vaginal, urethral and urine specimens (p = 0.9). Prevalence of M. genitalium is significantly higher in patients aged between 10-30 years (4.1%) compared to those aged between 30 and 50 years (2.7%) (p = 0.02, RR = 1.54 [1.06-2.24]) and patients over 50 years of age (1.1%) (p = 0.003, RR= 3.98 [1.47-10.8]). M. genitalium is a common agent of STI, therefore we suggest that this micro-organism should be systematically tested during chronic, recurrent, or antibiotic resistant genital infections and in populations at high-risk of STIs.
[Mh] Termos MeSH primário: Doenças Transmissíveis Emergentes/epidemiologia
Infecções por Mycoplasma/epidemiologia
Mycoplasma genitalium/isolamento & purificação
Doenças Bacterianas Sexualmente Transmissíveis/epidemiologia
[Mh] Termos MeSH secundário: Adolescente
Adulto
Idoso
Idoso de 80 Anos ou mais
Criança
Doenças Transmissíveis Emergentes/microbiologia
Feminino
França/epidemiologia
Hospitais Universitários
Seres Humanos
Masculino
Meia-Idade
Infecções por Mycoplasma/microbiologia
Prevalência
Reação em Cadeia da Polimerase em Tempo Real
Doenças Bacterianas Sexualmente Transmissíveis/microbiologia
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170925
[Lr] Data última revisão:
170925
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170802
[St] Status:MEDLINE
[do] DOI:10.1111/apm.12731


  10 / 538 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28640054
[Au] Autor:Heavey E
[Ad] Endereço:Elizabeth Heavey is a certified nurse midwife, epidemiologist, and professor of nursing at SUNY Brockport in Brockport, N.Y. She also serves as an editorial board member for Nursing2017.
[Ti] Título:Mycoplasma genitalium.
[So] Source:Nursing;47(7):61-62, 2017 07.
[Is] ISSN:1538-8689
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Infecções por Mycoplasma
[Mh] Termos MeSH secundário: Coinfecção
Infecções por HIV/epidemiologia
Seres Humanos
Infecções por Mycoplasma/complicações
Infecções por Mycoplasma/epidemiologia
Infecções por Mycoplasma/enfermagem
Infecções por Mycoplasma/terapia
Mycoplasma genitalium/isolamento & purificação
Guias de Prática Clínica como Assunto
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171026
[Lr] Data última revisão:
171026
[Sb] Subgrupo de revista:N
[Da] Data de entrada para processamento:170623
[St] Status:MEDLINE
[do] DOI:10.1097/01.NURSE.0000520524.30192.07



página 1 de 54 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde